Seer (NASDAQ: SEER)
$2.45
(1.7%)
$0.04
Price as of January 7, 2025, 4:00 p.m. ET
Seer Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Seer Company Info
Seer, Inc. (California) engages in the development of proprietary engineered nanoparticles to provide access across the proteome. Its Proteograph product suite comprises automation instrument and software, which provides workflow to make proteomic profiling. The company was founded by Philip Ma, Robert S. Langer Jr. and Omid C. Farokhzad on March 16, 2017 and is headquartered in Redwood City, CA.
News & Analysis
Featured Article
Why Shares of Seer Are Slumping Wednesday
The company reported a net loss but improved revenue in the second quarter.
Jim Halley | Aug 9, 2023
Featured Article
CEO of Newly IPO'd Seer: For Biotech Investors, Proteins Are The New DNA
Seer's CEO Dr. Omid Farokhzad describes the revolutionary potential in the proteomics sector and what investors should know.
Corinne Cardina Jurney | Jun 2, 2021
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.